Ryan Kubota | Executive Director of Investor Relations |
Keith Katkin | Chief Executive Officer |
Cornelia Haag-Molkenteller | Chief Medical Officer |
Christine Ocampo | Chief Accounting Officer |
Ajay Bansal | Senior Vice President, Business Development and Chief Financial Officer |
Turner Kufe | JPMorgan |
Edward Marks | H.C. Wainwright & Co. |
Joon Lee | SunTrust Robinson Humphrey Inc. |
Ladies and gentlemen, thank you for standing by, and welcome to the Urovant Sciences Fiscal 2019 Second Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Following management’s prepared remarks, we will hold a question-and-answer session. [Operator Instructions] As a reminder, today’s conference is being recorded.
I’d like to turn the conference over to Ryan Kubota, Executive Director of Investor Relations.